ATLASBioAge Labs (BIOA) earnings date: Nov 5, 2026
BioAge Labs (BIOA) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, after the close. Analysts expect EPS of -$0.68.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on BIOA
| Last price | $5.76 (-1.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.5% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the BioAge Labs stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
BioAge Labs reports on Nov 5, 2026. One email the day before, with ATLAS’s read on BioAge Labs. You can switch it off at any time.
Alert me before BIOA reportsFree to start. Creating an account takes under a minute.
Notify me when BioAge Labs reports
Track BIOA free Add BioAge Labs to a free ATLAS watchlist and see its next report date in one place.
BIOA earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.68 |
| Last report | Aug 5, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +4.6% |
| Average move around a report | ±3.4% (last 5) |
| Sector | Healthcare · Drug Manufacturers - Specialty & Generic |
BioAge Labs earnings history: last 5 reports
BioAge Labs last reported on Aug 5, 2026: EPS of -$0.58 against an estimate of -$0.62 (+6.5% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 5, 2026 | -$0.62 | -$0.58 | +6.5% | Beat | +0.6% |
| May 8, 2026 | -$0.63 | -$0.52 | +17.5% | Beat | +1.9% |
| Apr 15, 2026 | $0.50 | $0.53 | +6.0% | Beat | +2.5% |
| Mar 24, 2026 | -$0.67 | -$0.72 | -7.5% | Miss | -11.9% |
| Feb 3, 2026 | $3.32 | $3.33 | +0.3% | In line | +0.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for BIOA
See the fair value, the probability range and the earnings history of BioAge Labs on its ATLAS page.
BioAge Labs (BIOA) stock analysisPlans from €3.99 a month.
BioAge Labs earnings: frequently asked questions
When does BioAge Labs (BIOA) report earnings?
BioAge Labs is scheduled to report on Thursday, November 5, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for BIOA?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.68 per share (USD). Estimates can change before the report.
How often does BIOA beat earnings estimates?
Of its last 5 reports with a recorded result, BioAge Labs beat the EPS estimate 3 times; the average surprise was +4.6%. Past results do not predict the next one.
How much does BIOA move around earnings?
Over its last 5 reports the stock moved an average of 3.4% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
Did BioAge Labs beat earnings estimates last quarter?
BioAge Labs last reported on Aug 5, 2026: EPS of -$0.58 against an estimate of -$0.62 (+6.5% surprise), a beat.
How much does BIOA usually move in a day?
On a normal trading day the ATLAS model puts BIOA’s one-day range at about ±5.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer